These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9559780)

  • 61. Nebulization of four commercially available amphotericin B formulations in persistently granulocytopenic rats with invasive pulmonary aspergillosis: evidence for long-term biological activity.
    Ruijgrok EJ; Fens MH; Bakker-Woudenberg IA; van Etten EW; Vulto AG
    J Pharm Pharmacol; 2005 Oct; 57(10):1289-95. PubMed ID: 16259757
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Emerging Role of Sphingolipids in Amphotericin B Drug Resistance.
    Madaan K; Bari VK
    Microb Drug Resist; 2023 Aug; 29(8):319-332. PubMed ID: 37327022
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison of amphotericin B lipid complex with amphotericin B and SCH 39304 in the treatment of murine coccidioidal meningitis.
    Allendoerfer R; Yates RR; Sun SH; Graybill JR
    J Med Vet Mycol; 1992; 30(5):377-84. PubMed ID: 1469539
    [TBL] [Abstract][Full Text] [Related]  

  • 64. In vitro and in vivo activities of NS-718, a new lipid nanosphere incorporating amphotericin B, against Aspergillus fumigatus.
    Otsubo T; Maesaki S; Hossain MA; Yamamoto Y; Tomono K; Tashiro T; Seki J; Tomii Y; Sonoke S; Kohno S
    Antimicrob Agents Chemother; 1999 Mar; 43(3):471-5. PubMed ID: 10049253
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Interactions of liposomal amphotericin B with extracellular and intracellular Candida albicans.
    van Etten EW; Chander HR; Snijders SV; Bakker-Woudenberg IA
    J Antimicrob Chemother; 1995 Dec; 36(6):961-74. PubMed ID: 8821595
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A head-on comparison of the in vitro antifungal activity of conventional and lipid-based amphotericin B: a multicenter study.
    Jessup C; Reyes G; Fothergill A; McCarthy D; Rinaldi M; Messer S; Pfaller M; Ghannoum M
    J Chemother; 2000 Feb; 12(1):22-9. PubMed ID: 10768512
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Release of prostaglandin E-2 in bovine brain endothelial cells after exposure to three unique forms of the antifungal drug amphotericin-B: role of COX-2 in amphotericin-B induced fever.
    McGuire TR; Trickler WJ; Hock L; Vrana A; Hoie EB; Miller DW
    Life Sci; 2003 Apr; 72(23):2581-90. PubMed ID: 12672504
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparative in vitro and in vivo evaluation of N-D-ornithyl amphotericin B methyl ester, amphotericin B methyl ester, and amphotericin B.
    Parmegiani RM; Loebenberg D; Antonacci B; Yarosh-Tomaine T; Scupp R; Wright JJ; Chiu PJ; Miller GH
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1756-60. PubMed ID: 3324961
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Retrospective study of the renal effects of amphotericin B lipid complex when used at higher-than-recommended dosages and longer durations compared with lower dosages and shorter durations in patients with systemic fungal infections.
    Hooshmand-Rad R; Reed MD; Chu A; Gotz V; Morris JA; Weinberg J; Dominguez EA
    Clin Ther; 2004 Oct; 26(10):1652-62. PubMed ID: 15598482
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Amphotericin B-copper(II) complex shows improved therapeutic index in vitro.
    Chudzik B; Czernel G; Miaskowski A; Gagoś M
    Eur J Pharm Sci; 2017 Jan; 97():9-21. PubMed ID: 27816628
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of amphotericin B lipid complex (ABLC) vs. ambisome in the treatment of suspected or documented fungal infections in patients with leukemia.
    Fleming RV; Kantarjian HM; Husni R; Rolston K; Lim J; Raad I; Pierce S; Cortes J; Estey E
    Leuk Lymphoma; 2001 Feb; 40(5-6):511-20. PubMed ID: 11426524
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system.
    Groll AH; Giri N; Petraitis V; Petraitiene R; Candelario M; Bacher JS; Piscitelli SC; Walsh TJ
    J Infect Dis; 2000 Jul; 182(1):274-82. PubMed ID: 10882607
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening systemic mycoses.
    Wingard JR
    Bone Marrow Transplant; 1997 Feb; 19(4):343-7. PubMed ID: 9051244
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Assessment of in vitro antifungal efficacy and in vivo toxicity of Amphotericin B-loaded PLGA and PLGA-PEG blend nanoparticles.
    Moraes Moreira Carraro TC; Altmeyer C; Maissar Khalil N; Mara Mainardes R
    J Mycol Med; 2017 Dec; 27(4):519-529. PubMed ID: 28797532
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Amphotericin B-silver hybrid nanoparticles: synthesis, properties and antifungal activity.
    Tutaj K; Szlazak R; Szalapata K; Starzyk J; Luchowski R; Grudzinski W; Osinska-Jaroszuk M; Jarosz-Wilkolazka A; Szuster-Ciesielska A; Gruszecki WI
    Nanomedicine; 2016 May; 12(4):1095-1103. PubMed ID: 26772425
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of amphotericin B incorporated into liposomes and in lipid suspensions in the treatment of murine candidiasis.
    Kretschmar M; Nichterlein T; Hannak D; Hof H
    Arzneimittelforschung; 1996 Jul; 46(7):711-5. PubMed ID: 8842344
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Preferential distribution of amphotericin B lipid complex into human HDL3 is a consequence of high density lipoprotein coat lipid content.
    Kennedy AL; Wasan KM
    J Pharm Sci; 1999 Nov; 88(11):1149-55. PubMed ID: 10564063
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [The effect of propyl gallate on the activity of various antifungal drugs against filamentous fungi in vitro].
    Xu Y; Pang GR; Lü XF; Chen ZJ; Sun ST; Song JZ
    Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):309-12. PubMed ID: 16762206
    [TBL] [Abstract][Full Text] [Related]  

  • 79. In vitro activities of amphotericin B and AmBisome against Aspergillus isolates recovered from Italian patients treated for haematological malignancies.
    Colozza C; Posteraro B; Santilli S; De Carolis E; Sanguinetti M; Girmenia C
    Int J Antimicrob Agents; 2012 May; 39(5):440-3. PubMed ID: 22429723
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Amphotericin B lipid complex is efficacious in the treatment of Candida albicans biofilms using a model of catheter-associated Candida biofilms.
    Mukherjee PK; Long L; Kim HG; Ghannoum MA
    Int J Antimicrob Agents; 2009 Feb; 33(2):149-53. PubMed ID: 18945596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.